These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 27902863)

  • 1. Evaluation of recurrent high-grade gliomas treated with bevacizumab: A preliminary report of 3D pseudocontinuous artery spin labeling.
    Lyu Y; Liu S; You H; Hou B; Wang Y; Ma W; Feng F
    J Magn Reson Imaging; 2017 Aug; 46(2):565-573. PubMed ID: 27902863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of intravoxel incoherent motion magnetic resonance imaging and arterial spin labeling for recurrent glioma after bevacizumab treatment.
    Miyoshi F; Shinohara Y; Kambe A; Kuya K; Murakami A; Kurosaki M; Ogawa T
    Acta Radiol; 2018 Nov; 59(11):1372-1379. PubMed ID: 29471670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative cerebral blood volume is a potential predictive imaging biomarker of bevacizumab efficacy in recurrent glioblastoma.
    Kickingereder P; Wiestler B; Burth S; Wick A; Nowosielski M; Heiland S; Schlemmer HP; Wick W; Bendszus M; Radbruch A
    Neuro Oncol; 2015 Aug; 17(8):1139-47. PubMed ID: 25754089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral Blood Flow Changes in Glioblastoma Patients Undergoing Bevacizumab Treatment Are Seen in Both Tumor and Normal Brain.
    Andre JB; Nagpal S; Hippe DS; Ravanpay AC; Schmiedeskamp H; Bammer R; Palagallo GJ; Recht L; Zaharchuk G
    Neuroradiol J; 2015 Apr; 28(2):112-9. PubMed ID: 25923677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of 3-dimensional pseudocontinuous arterial spin labeling with dynamic contrast-enhanced perfusion magnetic resonance imaging in grading of human glioma.
    Roy B; Awasthi R; Bindal A; Sahoo P; Kumar R; Behari S; Ojha BK; Husain N; Pandey CM; Rathore RK; Gupta RK
    J Comput Assist Tomogr; 2013; 37(3):321-6. PubMed ID: 23673999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravoxel incoherent motion diffusion-weighted imaging analysis of diffusion and microperfusion in grading gliomas and comparison with arterial spin labeling for evaluation of tumor perfusion.
    Shen N; Zhao L; Jiang J; Jiang R; Su C; Zhang S; Tang X; Zhu W
    J Magn Reson Imaging; 2016 Sep; 44(3):620-32. PubMed ID: 26880230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging.
    Xu Q; Liu Q; Ge H; Ge X; Wu J; Qu J; Xu K
    Medicine (Baltimore); 2017 Dec; 96(50):e9332. PubMed ID: 29390403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of arterial spin labeling imaging for predicting prognosis after a recurrence of high-grade glioma in patients under bevacizumab treatment.
    Kambe A; Kitao S; Ochiai R; Hosoya T; Fujii S; Kurosaki M
    J Neurooncol; 2024 Jan; 166(1):175-183. PubMed ID: 38165552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D-ASL perfusion correlates with VEGF expression and overall survival in glioma patients: Comparison of quantitative perfusion and pathology on accurate spatial location-matched basis.
    Pang H; Dang X; Ren Y; Zhuang D; Qiu T; Chen H; Zhang J; Ma N; Li G; Zhang J; Wu J; Feng X
    J Magn Reson Imaging; 2019 Jul; 50(1):209-220. PubMed ID: 30652410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D Pseudocontinuous Arterial Spin-Labeling MR Imaging in the Preoperative Evaluation of Gliomas.
    Zeng Q; Jiang B; Shi F; Ling C; Dong F; Zhang J
    AJNR Am J Neuroradiol; 2017 Oct; 38(10):1876-1883. PubMed ID: 28729293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?
    Palmer JD; Bhamidipati D; Song A; Eldredge-Hindy HB; Siglin J; Dan TD; Champ CE; Zhang I; Bar-Ad V; Kim L; Glass J; Evans JJ; Andrews DW; Werner-Wasik M; Shi W
    J Neurooncol; 2018 Dec; 140(3):623-628. PubMed ID: 30182159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method.
    Cebeci H; Aydin O; Ozturk-Isik E; Gumus C; Inecikli F; Bekar A; Kocaeli H; Hakyemez B
    Eur J Radiol; 2014 Oct; 83(10):1914-9. PubMed ID: 25087109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced perfusion in normal-appearing white matter in mild to moderate hypertension as revealed by 3D pseudocontinuous arterial spin labeling.
    Wang T; Li Y; Guo X; Huang D; Ma L; Wang DJ; Lou X
    J Magn Reson Imaging; 2016 Mar; 43(3):635-43. PubMed ID: 26256700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Misleading early blood volume changes obtained using ferumoxytol-based magnetic resonance imaging perfusion in high grade glial neoplasms treated with bevacizumab.
    Netto JP; Schwartz D; Varallyay C; Fu R; Hamilton B; Neuwelt EA
    Fluids Barriers CNS; 2016 Dec; 13(1):23. PubMed ID: 27998280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change in 18F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment.
    Yamaguchi S; Hirata K; Toyonaga T; Kobayashi K; Ishi Y; Motegi H; Kobayashi H; Shiga T; Tamaki N; Terasaka S; Houkin K
    PLoS One; 2016; 11(12):e0167917. PubMed ID: 27936194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application value of whole brain 3D artery spin labeling in diagnosis of intracranial tumors].
    Zhao QQ; Yang QX; Xu GX; Lü YC; Rong DL; Liu L; Zhang R
    Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(23):1801-1804. PubMed ID: 28648002
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence for improved survival with bevacizumab treatment in recurrent high-grade gliomas: a retrospective study with ("pseudo-randomized") treatment allocation by the health insurance provider.
    Hofmann S; Schmidt MA; Weissmann T; Eyüpoglu I; Strnad A; Semrau S; Fietkau R; Putz F; Lettmaier S
    J Neurooncol; 2020 Jun; 148(2):373-379. PubMed ID: 32409944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three-dimensional pseudo-continuous arterial spin labeling perfusion imaging with gradient-echo and spin-echo dynamic susceptibility contrast MRI.
    Wong AM; Yan FX; Liu HL
    J Magn Reson Imaging; 2014 Feb; 39(2):427-33. PubMed ID: 23677620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of glioma response to radiotherapy using 3D pulsed-continuous arterial spin labeling and 3D segmented volume.
    Wang P; Li J; Diao Q; Lin Y; Zhang J; Li L; Yang G; Fang X; Li X; Chen Y; Zheng L; Lu G
    Eur J Radiol; 2016 Nov; 85(11):1987-1992. PubMed ID: 27776650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grading and outcome prediction of pediatric diffuse astrocytic tumors with diffusion and arterial spin labeling perfusion MRI in comparison with 18F-DOPA PET.
    Morana G; Piccardo A; Tortora D; Puntoni M; Severino M; Nozza P; Ravegnani M; Consales A; Mascelli S; Raso A; Cabria M; Verrico A; Milanaccio C; Rossi A
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2084-2093. PubMed ID: 28752225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.